参考文献
［1］Lontos K，Adamik J，Tsagianni A，et al.The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis.Front Endocrinol（Lausanne）.2018，9：322.
［2］Kamaleshwaran KK，Mittal BR，Harisankar CN，et al.Predictive value of serum prostate specific antigen in detecting bone metastasis in prostate cancer patients using bone scintigraphy.Indian J Nucl Med.2012，27（2）：81-4.
［3］Lorente JA，Morote J，Raventos C，et al.Clinical efficacy of bone alkaline phosphatase and prostate specific antigen in the diagnosis of bone metastasis in prostate cancer.J Urol.1996，155（4）：1348-51.
［4］Fonseca L，Cicuendez M，Martinez-Ricarte F，et al.A rare case of an intramedullary metastasis of a myxopapillary ependymoma.Surg Neurol Int.2019，10：83.
［5］Kokkalis P，Chamilos C，Sgouros S.Primary Spinal Glioblastoma Multiforme with Cerebral Parenchymal Metastasis in a Child.PediatrNeurosurg.2016，51（6）：325-6.
［6］Khan S，Son H.Spinal Metastasis Characterized on FDG PET/CT in Head and Neck Squamous Cell Carcinoma.Clin Nucl Med.2017，42（11）：860-1.
［7］Deckey DG，Reid DBC，Mallozzi S，et al.Cutaneous Metastasis via Surgical Planes After Lumbar Spinal Reconstruction for Spinal Metastatic Disease.World Neurosurg.2019，123：49-53.
［8］Barlev A，Song X，Ivanov B，et al.Payer costs for inpatient treatment of pathologic fracture，surgery to bone，and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer.J Manag Care Pharm.2010，16（9）：693-702.
［9］Seo DK，Park JH，Oh SK，et al.Practicality of using the figure-of-eight bandage to prevent fatal wound dehiscence after spinal tumor surgery for upper thoracic metastasis.Br J Neurosurg.2018，32（4）：389-95.
［10］Alqahtani A，Amer R，Bakhsh E.Primary Occipital Ewing's Sarcoma with Subsequent Spinal Seeding.Case Rep Pediatr.2017，2017：1521407.
［11］Cheng X，Long HQ，Xu JH，et al.Comparison of unilateral versus bilateral percutaneous kyphoplasty for the treatment of patients with osteoporosis vertebral compression fracture（OVCF）：a systematic review and meta-analysis.Eur Spine J.2016，25（11）：3439-49.
［12］Paccou J，Michou L，Kolta S，et al.High bone mass in adults.Joint Bone Spine.2018，85（6）：693-9.
［13］LINHY.Leukemoid reaction in malignant tumor（a report of 23cases）.Clin Misdiagn Misther，2018，21（7）：32-33.
［14］Swierczak A，Mouchemore KA，Hamilton JA：important contributors to tumor progression and metastasis.Cancer Metastasis Rev，2015，34（4）：735-751.
［15］Blomqvist C，Risteli L，Risteli J，et al.Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma［J］.Br J Cancer，1996，73（9）：1074-1079.
［16］Demers LM，Costa L，Lipton A.Biochemical markers and skeletal metastases.Cancer，2000，88：2919-26.
［17］Zhao H，Han KL，Wang ZY，et al.Value of C-telopeptide-cross-linked Type I collagen，osteocalcin，bone-specific alkaline phosphatase and procollagen Type I N-terminal propeptide in the diagnosis and prognosis of bone metastasis in patients with malignant tumors.Med Sci Monit，2011，17（11）：CR626-633.
［18］Diel IJ，Mundy GR.Bisphosphonates in the adjuvant treatment of cancer：experimental evidence and first clinical results.International Bone and Cancer Study Group（IBCG）.Br J Cancer.2000；82（8）：1381-1386.
［19］D'Oronzo S，Brown J，Coleman R.The role of biomarkers in the management of bone-homing malignancies.J Bone Oncol，2017；9：1-9.
［20］Zhang J，Chen G，Zhang P，et al.The threshold of alpha-fetoprotein（AFP）for the diagnosis of hepatocellular carcinoma：A systematic review and meta-analysis.PLoS One，2020，15（2）：e0228857.
［21］Brown J，Rathbone E，Hinsley S，et al.Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis：Results From the AZURE（BIG01/04）Trial.？J Natl Cancer Inst.2018；110（8）：871-879.
［22］Skovrlj B，Koehler SM，Anderson PA，et al.Association Between BMP-2 and Carcinogenicity.？Spine（Phila Pa 1976）.2015；40（23）：1862-1871.
［23］Mitsui Y，Hirata H，Arichi N，et al.Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.Oncotarget.2015；6（11）：9577-9591.(https://www.daowen.com)
［24］Hall C，Clarke L，Pal A，et al.A Review of the Role of Carcinoembryonic Antigen in Clinical Practice.Ann Coloproctol，2019，35（6）：294-305.
［25］Necula L，Matei L，Dragu D，et al.Recent advances in gastric cancer early diagnosis.World J Gastroenterol，2019，25（17）：2029-2044.
［26］Dochez V，Caillon H，Vaucel E，et al.Biomarkers and algorithms for diagnosis of ovarian cancer：CA125，HE4，RMI and ROMA，a review.J Ovarian Res，2019，12（1）：28.
［27］KotzevAl，DraganovPV.Carbohydrate Antigen 19-9，Carcinoembryonic Antigen，and Carbohydrate Antigen 72-4 in Gastric Cancer：Is the Old Band Still Playing？.Gastrointest Tumors，2018，5（1-2）：1-13.
［28］Li X，DaiD，ChenB，etal.Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer：A Meta-Analysis including 12，993 Patients.Dis Markers，2018，2018：9863092.
［29］Li X，XuY，ZhangL.Serum CA153 as biomarker for cancer and noncancer diseases.Prog Mol Biol Transl Sci，2019，162：265-276.
［30］Lin Y，MaoQ，ChenB，etal.When to perform bone scintigraphy in patients with newly diagnosed prostate cancer？a retrospective study.BMC Urol，2017；17：41-5.
［31］IsgròMA，BottoniP，ScatenaR.Neuron-Specific Enolase as a Biomarker：Biochemical and Clinical Aspects.Adv Exp Med Biol，2015，867：125-143.
［32］CharakornC，ThadaniponK，ChaijindaratanaS，etal.The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma：A systematic review and meta-analysis.Gynecol Oncol，2018，150（1）：190-200.
［33］Yang G，XiaoZ，TangC，etal.Recent advances in biosensor for detection of lung cancer biomarkers..BiosensBioelectron，2019，141：111-416.
［34］Huang YL，ChenJ，YanW，etal.Diagnostic accuracy of cytokeratin-19 fragment（CYFRA 21-1）for bladder cancer：a systematic review and meta-analysis.Tumour Biol，2015，36（5）：3137-3145.
［35］Fletcher CD，BridgeJA，HogendoornPC，etal.World Health Organization classification of soft tissue and bone tumors.Lyon：IARC Press，2013.
［36］Larousserie F，Genestie C.Anatomopathologie des métastasesosseuses（particularités techniques，recherche du primitif）［Histology of bone metastases（technical aspects，searching for a primary）］.Bull Cancer，2013，100（11）：1101-1108.
［37］BochtlerT，L？ffler H，Kr？mer A.Diagnosis and management of metastatic neoplasms with unknown primary.Semin Diagn Pathol，2018，35（3）：199-206.
［38］Yasui H，Ozawa N，Mikami S，et al.Spinal Cord Ischemia Secondary to Epidural Metastasis from Small Cell Lung Carcinoma.Am J Case Rep，2017，18：276-280.
［39］Arshad HS，Dudekula RA，Niazi M，et al.A Rare Case of Sarcomatoid Carcinoma of the Lung with Spine Metastasis，Including a Literature Review.Am J Case Rep，2017，18：760-765.
［40］Aycan A，Celik S，Kuyumcu F，et al.Spinal Metastasis of Unknown Primary Accompanied by Neurologic Deficit or Vertebral Instability.World Neurosurg，2018，109：e33-42.
［41］Asch-Kendrick R，Cimino-Mathews A.The role of GATA3 in breast carcinomas：a review.Hum Pathol，2016，48：37-47.
［42］Srinivasan M，Parwani AV.Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma.Diagn Pathol，2011，6：67.
［43］Lee KR，Maeng YH.Solitary Spinal Epidural Metastasis from Prostatic Small Cell Carcinoma.Case Rep Radiol，2016，2016：4728343.14.Goodwin CR，Ahmed AK，Boone C，et al.The Challenges of Renal Cell Carcinoma Metastatic to the Spine：A Systematic Review of Survival and Treatment.Global Spine J，2018，8（5）：517-526.
［44］Zeng Y，Chen H，Xiang Z，et al.Nasopharyngeal carcinoma with metastasis to the central nervous system：a report of two patients and review of the literature.Int J Clin Exp Pathol，2019，12（11）：4142-4149.
［45］Zamborsky R，Svec A，Kokavec M，Galbavy S.Bone metastases in neuroendocrine tumors.Bratisl Lek Listy，2017，118（9）：529-534.
［46］SonawaneR，GhoshalA，DamaniA，MuckadenM，Deodhar JK.Intramedullary Spinal Cord Metastases of Malignant Melanoma：A Rare Case Report on Paraplegia in Palliative Care.Indian J Palliat Care，2019，25（3）：468-470.